Agilent Technologies Free Cash Flow 2010-2025 | A
Agilent Technologies annual/quarterly free cash flow history and growth rate from 2010 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Agilent Technologies free cash flow for the quarter ending January 31, 2025 was 334.00, a year-over-year.
- Agilent Technologies free cash flow for the twelve months ending January 31, 2025 was , a year-over-year.
- Agilent Technologies annual free cash flow for 2024 was $1.373B, a 6.85% decline from 2023.
- Agilent Technologies annual free cash flow for 2023 was $1.474B, a 44.37% increase from 2022.
- Agilent Technologies annual free cash flow for 2022 was $1.021B, a 21.34% decline from 2021.
| Agilent Technologies Annual Free Cash Flow |
| 2024 |
1,373.00 |
| 2023 |
1,474.00 |
| 2022 |
1,021.00 |
| 2021 |
1,298.00 |
| 2020 |
803.00 |
| 2019 |
866.00 |
| 2018 |
911.00 |
| 2017 |
713.00 |
| 2016 |
654.00 |
| 2015 |
426.00 |
| 2014 |
540.00 |
| 2013 |
959.00 |
| 2012 |
1,034.00 |
| 2011 |
1,090.00 |
| 2010 |
604.00 |
| 2009 |
281.00 |
| Agilent Technologies Quarterly Free Cash Flow |
| 2025-01-31 |
334.00 |
| 2024-10-31 |
1,373.00 |
| 2024-07-31 |
985.00 |
| 2024-04-30 |
625.00 |
| 2024-01-31 |
395.00 |
| 2023-10-31 |
1,474.00 |
| 2023-07-31 |
1,042.00 |
| 2023-04-30 |
561.00 |
| 2023-01-31 |
220.00 |
| 2022-10-31 |
1,021.00 |
| 2022-07-31 |
643.00 |
| 2022-04-30 |
399.00 |
| 2022-01-31 |
180.00 |
| 2021-10-31 |
1,298.00 |
| 2021-07-31 |
918.00 |
| 2021-04-30 |
638.00 |
| 2021-01-31 |
197.00 |
| 2020-10-31 |
803.00 |
| 2020-07-31 |
453.00 |
| 2020-04-30 |
187.00 |
| 2020-01-31 |
-93.00 |
| 2019-10-31 |
866.00 |
| 2019-07-31 |
582.00 |
| 2019-04-30 |
387.00 |
| 2019-01-31 |
174.00 |
| 2018-10-31 |
911.00 |
| 2018-07-31 |
574.00 |
| 2018-04-30 |
410.00 |
| 2018-01-31 |
155.00 |
| 2017-10-31 |
713.00 |
| 2017-07-31 |
483.00 |
| 2017-04-30 |
298.00 |
| 2017-01-31 |
84.00 |
| 2016-10-31 |
654.00 |
| 2016-07-31 |
472.00 |
| 2016-04-30 |
302.00 |
| 2016-01-31 |
73.00 |
| 2015-10-31 |
426.00 |
| 2015-07-31 |
211.00 |
| 2015-04-30 |
122.00 |
| 2015-01-31 |
-52.00 |
| 2014-10-31 |
540.00 |
| 2014-07-31 |
399.00 |
| 2014-04-30 |
423.00 |
| 2014-01-31 |
149.00 |
| 2013-10-31 |
959.00 |
| 2013-07-31 |
614.00 |
| 2013-04-30 |
452.00 |
| 2013-01-31 |
187.00 |
| 2012-10-31 |
1,034.00 |
| 2012-07-31 |
611.00 |
| 2012-04-30 |
420.00 |
| 2012-01-31 |
104.00 |
| 2011-10-31 |
1,090.00 |
| 2011-07-31 |
629.00 |
| 2011-04-30 |
409.00 |
| 2011-01-31 |
82.00 |
| 2010-10-31 |
604.00 |
| 2010-07-31 |
265.00 |
| 2010-04-30 |
202.00 |
| 2010-01-31 |
5.00 |
| 2009-10-31 |
281.00 |
| 2009-07-31 |
97.00 |
| 2009-04-30 |
86.00 |
| 2009-01-31 |
-17.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$30.971B |
$6.510B |
|
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
|
